Trials / Completed
CompletedNCT03533920
Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular Carcinoma
A Single-arm, Multicenter, Open, Pivotal Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular Carcinoma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- Jeil Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
Pivotal Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular Carcinoma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | UNI-DEB | Applicate the TACE with UNI-DEB to unresectable hepatocellular carcinoma patient |
Timeline
- Start date
- 2017-10-25
- Primary completion
- 2018-06-30
- Completion
- 2018-09-03
- First posted
- 2018-05-23
- Last updated
- 2018-10-01
Locations
8 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03533920. Inclusion in this directory is not an endorsement.